Sec Form 13G Filing - Iliad Research & Trading, L.P. filing for CardioGenics Holdings Inc (CGNH) - 2025-03-11

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Reporting Person Iliad Research & Trading, LP ("Iliad") has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  Iliad Management, LLC is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  Fife Trading, Inc. is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  John Fife is the president of Fife Trading, Inc. which is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G


 
Iliad Research & Trading, L.P.
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
Iliad Management, LLC
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
Fife Trading, Inc.
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
John M Fife
 
Signature:John Fife
Name/Title:John Fife
Date:03/11/2025
primary_doc.xml